YEAST is a renowned peer-reviewed journal published by WILEY, dedicated to advancing the understanding of yeast biology and its applications in various scientific fields. Since its inception in 1985, YEAST has significantly contributed to the disciplines of microbiology, biotechnology, biochemistry, and genetics, achieving respectable rankings within its categories, including Q2 status in Applied Microbiology and Biotechnology and Q2 in Biotechnology as of 2023. With an emphasis on high-quality research, it explores diverse aspects of yeast organisms, from their cellular mechanisms to biotechnological applications. Although it does not currently offer an open-access option, the journal provides valuable insights and findings that are applicable to both academia and industry, making it an essential resource for researchers, professionals, and students interested in the functional and applied dimensions of yeast. With its editorial rigor and commitment to quality, YEAST continues to be a vital platform for disseminating innovative research that shapes future biotechnological advancements.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

BIOCHEMICAL GENETICS, published by Springer/Plenum Publishers, is a prominent journal in the fields of biochemistry, genetics, and molecular biology, with a substantial impact on the scientific community since its inception in 1967. The journal holds a significant position within various academic quartiles, ranking Q2 in Ecology, Evolution, Behavior and Systematics, and Q3 in Biochemistry, Genetics, and Medicine (miscellaneous), among others, demonstrating its diverse and interdisciplinary reach. With an ISSN of 0006-2928 and an E-ISSN of 1573-4927, it is recognized for contributing critical research insights and methodologies that drive the fields of biochemical genetics forward. Although it is not an Open Access journal, it provides vital access options and resources for researchers globally, facilitating the dissemination of knowledge across institutions. Positioned within the competitive landscape of Scopus rankings, it maintains respectable standings across its focused areas, making it an invaluable resource for researchers, professionals, and students seeking to deepen their understanding of genetic mechanisms and biochemical processes.

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.

American Journal of Physiology-Endocrinology and Metabolism, published by the American Physiological Society, stands as a leading platform for disseminating high-quality research in the fields of endocrinology, diabetes, and metabolism, as well as general physiology. With an impressive impact factor placing it within the Q1 category across multiple relevant disciplines (Endocrinology, Diabetes and Metabolism; Physiology; and Medical Physiology), this journal reflects its authoritative position in the scientific community. Spanning from 1980 to 2024, the journal consistently publishes groundbreaking studies and significant findings that advance our understanding of hormonal regulation and metabolic processes. Although it does not currently offer open access, it provides valuable resources for researchers, professionals, and students alike, eager to stay at the forefront of advancements in physiological sciences. Addressed in Rockville, Maryland, its commitment to excellence and rigorous peer review ensures that every article contributes essential insights to the field.

TRENDS IN ENDOCRINOLOGY AND METABOLISM, published by CELL PRESS, stands as a pivotal resource in the fields of endocrinology, diabetes, and metabolism. With its ISSN 1043-2760 and E-ISSN 1879-3061, this esteemed journal has been a leading platform since its inception in 1989, currently projected to span until 2024. Recognized within the top quartile (Q1) of its category, it boasts impressive Scopus rankings, holding the 4th position in Endocrinology and 8th in Endocrinology, Diabetes, and Metabolism. These rankings underscore its significant impact, evidenced by an impressive percentile rank of 97th and 96th respectively. The journal is committed to facilitating the dissemination of cutting-edge research and innovative insights, making it an essential read for researchers, clinicians, and students seeking to stay informed on the latest advancements in these critical fields. With a robust focus on providing thorough reviews and original research articles, TRENDS IN ENDOCRINOLOGY AND METABOLISM continues to shape the understanding and treatment of metabolic disorders.

FUNCTIONAL & INTEGRATIVE GENOMICS, published by Springer Heidelberg, is a leading journal in the fields of genetics and molecular biology. Established in 2000, it serves as a pivotal platform for advancing our understanding of genomic functionality and integration, making significant contributions to both basic and applied research in genetics. With a robust impact factor and a ranking in the Q3 quartile for Genetics and Q2 for Medicine (Miscellaneous), the journal aims to publish innovative research that explores the relationships between genomic data and biological functions, appealing to a diverse audience of researchers and professionals. Although it operates under a subscription model, the journal's extensive archives remain a valuable resource for academics seeking to stay abreast of the latest findings and methodologies in genomics. As the field evolves, FUNCTIONAL & INTEGRATIVE GENOMICS remains committed to fostering scholarly dialogue and the dissemination of groundbreaking studies that influence future research trajectories.

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.

Cold Spring Harbor Perspectives in Medicine is a premier academic journal published by the esteemed COLD SPRING HARBOR LAB PRESS that has become a crucial resource in the fields of Biochemistry, Genetics, and Medicine. With an impressive impact factor and consistently ranked in the Q1 quartile for both biochemistry and general medicine—as evidenced by its Scopus rankings of #21 and #26 respectively—this journal serves as an essential platform for disseminating high-quality research and comprehensive reviews from leading experts. Covering a convergence of knowledge spanning from 2011 through 2024, it plays a vital role in advancing the understanding of medical science. Researchers, professionals, and students alike benefit from Cold Spring Harbor Perspectives in Medicine, which offers a depth of insight into critical topics, emerging trends, and essential developments within the medical community. Join the conversation and contribute to the ongoing dialogue that drives innovation and excellence in medical research.

CLINICAL ENDOCRINOLOGY, published by Wiley, is a premier journal in the field of endocrinology, providing a vital platform for the dissemination of cutting-edge research and advancements in the diagnosis and treatment of endocrine disorders. Since its inception in 1972, this prestigious journal has maintained its commitment to excellence with its scope encompassing diverse areas within endocrinology, diabetes, and metabolism, evidenced by its impressive ranking in the Q2 quartile for these categories as of 2023. With a growing impact factor, it serves as a leading reference for researchers and healthcare professionals dedicated to improving patient outcomes. Although the journal does not currently offer open access, it remains accessible through institutional subscriptions, ensuring that vital research reaches an expansive audience. Its robust focus on clinical applications makes CLINICAL ENDOCRINOLOGY an essential resource for anyone involved in the evolving field of endocrinology, thereby underscoring its importance in shaping future research and practice in healthcare.